Literature DB >> 23835528

Shades of vulnerability: latent structures of clinical caseness in prodromal and early phases of schizophrenia.

Andrea Raballo1, Anna Meneghelli, Angelo Cocchi, Davide Sisti, Marco B L Rocchi, Andrea Alpi, Maria T Cascio, Antonio Preti, Kurt Maurer, Heinz Häfner.   

Abstract

The underlying structures of clinical caseness and need of care in prodromal (i.e., at-risk) and early phases of schizophrenia remain poorly characterized in their essential psycho-behavioral coherence. To identify the schizophrenia proneness-related subtypes within a population of young help-seekers referred to a dedicated, community-based early detection program (Programma 2000). A sample of consecutive referrals (n = 168) for suspected psychosis or first-episode schizophrenia spectrum psychosis received a detailed clinical assessment, including the early recognition inventory for the retrospective assessment of the onset of schizophrenia checklist. We used exploratory factor analysis (EFA) to determine the underlying dimensional structure and latent class analysis (LCA) to identify putative vulnerability subtypes. EFA identified four factors: dysphoria (irritability tension), paranoid autocentrism, introversive withdrawal, and disturbed subjective experience. LCA distinguished three classes, interpretable as carrying different degrees of "proneness to schizophrenia psychosis," which best captured the underlying continuum of clinical severity. The validity of the three classes was supported by distinct patterns of association with major clinical variables (i.e., diagnostic staging at referral). Vulnerability to schizophrenia psychosis in young help-seekers may manifest in three major clinical prototypes, presenting common levels of dysphoria and social withdrawal but different degrees of paranoid autocentrism and disturbed subjective experience. Overall, the results provide the empirical background to dissect shared features of clinical caseness from more schizophrenia-specific vulnerability components. This is of value for the refinement of the clinical staging model as well as for the pragmatic implementation of multiple-gate screening programs.

Entities:  

Mesh:

Year:  2013        PMID: 23835528     DOI: 10.1007/s00406-013-0421-4

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  57 in total

Review 1.  Self-centrality, psychosis and schizotaxia: a conceptual review.

Authors:  Andrea Raballo; Eva Lundgren; Emanuela Leuci; Stefania Fontò; Carlo Maggini
Journal:  Acta Biomed       Date:  2006-04

2.  Recruitment and treatment practices for help-seeking "prodromal" patients.

Authors:  Thomas H McGlashan; Jean Addington; Tyrone Cannon; Markus Heinimaa; Patrick McGorry; Mary O'Brien; David Penn; Diana Perkins; Raimo K R Salokangas; Barbara Walsh; Scott W Woods; Alison Yung
Journal:  Schizophr Bull       Date:  2007-05-04       Impact factor: 9.306

3.  Franco Basaglia, 1924-1980.

Authors:  Giovanni de Girolamo; Francesco Barale; Pierluigi Politi; Paolo Fusar-Poli
Journal:  Am J Psychiatry       Date:  2008-08       Impact factor: 18.112

4.  Early detection of schizophrenia: current evidence and future perspectives.

Authors:  Heinz Häfner; Kurt Maurer
Journal:  World Psychiatry       Date:  2006-10       Impact factor: 49.548

5.  Identification of young people at risk of psychosis: validation of Personal Assessment and Crisis Evaluation Clinic intake criteria.

Authors:  L J Phillips; A R Yung; P D McGorry
Journal:  Aust N Z J Psychiatry       Date:  2000-11       Impact factor: 5.744

6.  The ABC Schizophrenia Study: a preliminary overview of the results.

Authors:  H Häfner; K Maurer; W Löffler; W an der Heiden; P Munk-Jørgensen; M Hambrecht; A Riecher-Rössler
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1998-08       Impact factor: 4.328

Review 7.  Kraepelin and psychotic prodromal conditions.

Authors:  Joachim Klosterkötter; Frauke Schultze-Lutter; Stephan Ruhrmann
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-06       Impact factor: 5.270

Review 8.  The concept of basic symptoms in schizophrenic and schizoaffective psychoses.

Authors:  G Huber; G Gross
Journal:  Recenti Prog Med       Date:  1989-12

9.  The "close-in" or ultra high-risk model: a safe and effective strategy for research and clinical intervention in prepsychotic mental disorder.

Authors:  Patrick D McGorry; Alison R Yung; Lisa J Phillips
Journal:  Schizophr Bull       Date:  2003       Impact factor: 9.306

Review 10.  Staging in neuropsychiatry: a heuristic model for understanding, prevention and treatment.

Authors:  Patrick D McGorry
Journal:  Neurotox Res       Date:  2010-04-03       Impact factor: 3.911

View more
  6 in total

1.  The new risk variant CACNA1C and brain circuits in schizophrenia.

Authors:  Andrea Schmitt; Peter Falkai
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-03       Impact factor: 5.270

2.  Duration of the psychosis prodrome.

Authors:  Albert R Powers; Jean Addington; Diana O Perkins; Carrie E Bearden; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Daniel H Mathalon; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Thomas H McGlashan; Scott W Woods
Journal:  Schizophr Res       Date:  2019-12-02       Impact factor: 4.939

3.  Antipsychotic prescription, assumption and conversion to psychosis: resolving missing clinical links to optimize prevention through precision.

Authors:  TianHong Zhang; Andrea Raballo; JiaHui Zeng; RanPiao Gan; GuiSen Wu; YanYan Wei; LiHua Xu; XiaoChen Tang; YeGang Hu; YingYing Tang; HaiChun Liu; Tao Chen; ChunBo Li; JiJun Wang
Journal:  Schizophrenia (Heidelb)       Date:  2022-05-04

4.  Antipsychotics are related to psychometric conversion to psychosis in ultra-high-risk youth.

Authors:  Antonio Preti; Andrea Raballo; Anna Meneghelli; Angelo Cocchi; Maria Meliante; Simona Barbera; Lara Malvini; Emiliano Monzani; Mauro Percudani
Journal:  Early Interv Psychiatry       Date:  2021-05-05       Impact factor: 2.721

5.  Patients With First-Episode Psychosis are Not a Homogeneous Population: Implications for Treatment.

Authors:  Angelo Cocchi; Giorgio Cerati; Antonio Lora; Anna Meneghelli; Emiliano Monzani; Mauro Percudani; Lorenzo Petrovich; Fiorino Mirabella; Angelo Picardi; Antonio Preti
Journal:  Clin Pract Epidemiol Ment Health       Date:  2014-02-07

6.  Duration of Untreated Disorder and Cannabis Use: An Observational Study on a Cohort of Young Italian Patients Experiencing Psychotic Experiences and Dissociative Symptoms.

Authors:  Valerio Ricci; Giovanni Martinotti; Franca Ceci; Stefania Chiappini; Francesco Di Carlo; Julius Burkauskas; Ottavia Susini; Debora Luciani; Diego Quattrone; Domenico De Berardis; Mauro Pettorruso; Giuseppe Maina; Massimo Di Giannantonio
Journal:  Int J Environ Res Public Health       Date:  2021-11-30       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.